Novuspharma Press Release: Financial Results for the nine months ended 30 September 2003 Sofinnova

Actualités

Novuspharma Press Release: Financial Results for the nine months ended 30 September 2003

Publiée le 30/09/2003

Visiter le site internet www.novuspharma.com Télécharger le fichier 128_fichier_attache.pdf

2003

25/02/2003
ESMERTEC acquires Insignia JVM business assets and becomes master distributor of Insignia’s Java Virtual Machine solution e
20/03/2003
Sofinnova Partners and Sofinnova Ventures Host Inaugural CEO Day Conference
17/04/2003
Diatos expands its management team
28/04/2003
Jean-Bernard Schmidt says Europe's post-bubble VCs now have the right focus: "Technology and funding seed startups" : interview for BusinessWeek
02/05/2003
Ingenium publishes in Science groundbreaking results about the pathogenetic cause for motor neuron disease
14/05/2003
Novuspharma SpA Announces Financial Results for the Three Months Ended 31 March 2003
05/06/2003
Jean-Bernard Schmidt elected as Association Chairman in 20th year of EVCA
05/06/2003
FT.com : "Challenge for Schmidt in private equity"
05/06/2003
l'Agefi : Jean-Bernard Schmidt, un "venture capitalist" viscéral à la tête de l'association européenne du capital investissement
17/06/2003
Cell Therapeutics, Inc. (CTI) Adds Pixantrone to its Oncology Drug Pipeline and Extends Global Cancer Business through Merger with Novuspharma S.p.a.
07/07/2003
NovusPharma’s Pixantrone Regimen produces high response rates in relapsed aggressive lymphoma
28/07/2003
Servista enables Lloyds TSB to launch home energy and telephone services
07/08/2003
Novuspharma SpA Announces Financial Results for the Six Months Ended 30 June 2003
30/06/2003
Q2 Another Record for AtomZ
02/09/2003
Ingenium Appoints Dr. Klaus Dembowsky to Vice President Drug Discovery
10/09/2003
Neuro3d raises M€ 10 from Existing Shareholders
30/09/2003
Novuspharma Press Release: Financial Results for the nine months ended 30 September 2003
23/10/2003
Cell Therapeutics, Inc. and Novuspharma S.p.A Announce Shareholder Approval of Merger
28/10/2003
Cellzome Announces Research Collaboration with Johnson & Johnson R&D
13/11/2003
Esmertec Nets €23m in Over-Subscribed Funding Round
25/11/2003
IDM obtient un deuxième brevet au Japon
14/11/2003
Innate Pharma and Novo Nordisk A/S sign licensing deal which opensnew avenue in cancer immunotherapy
19/11/2003
Allergan et Exonhit initient leur premier criblage à haut flux sur une cible identifiée conjointement
19/11/2003
Allergan and Exonhit designate target for high throughput screening
02/12/2003
The pharmaceutical company Biolipox strengthens Board of Directors with a well known industrialist
10/12/2003
Addex Pharmaceuticals SA Signs Three year Clinical Development Partnership with Fulcrum Pharma
12/12/2003
Pixantrone Induces Impressive 77% Major Tumor Response Rate in Patients with Relapsed Aggressive Lymphoma when Substituted for Doxorubicin in CHOP Regimen
29/12/2003
Happy New Year 2004 !
19/12/2003
France Biotech Applauds the French Parliament’ Vote on the Status of the Young Innovative Company (YIC) in the 2004 Budget Bill
19/12/2003
France Biotech se réjouit de l'adoption du statut de la jeune entreprise innovante dans la loi de finance 2004

Découvrez le site Sofinnova Ventures, notre société soeur à San Francisco http://www.sofinnova.com